{"filing":{"accession_number":"0001015820-26-000049","cik":"0001015820","ticker":"QGEN","company_name":"QIAGEN N.V.","form":"6-K","filing_date":"2026-08-07","report_date":"2026-06-30","primary_document":"a2026q2prform6-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1015820/000101582026000049/a2026q2prform6-k.htm"},"events":[{"id":26050,"run_id":23658,"accession_number":"0001015820-26-000049","anchor_item_number":"EX-99.1","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"This is a media release announcing QIAGEN's Q2 2026 financial results, including net sales of $535 million, adjusted diluted EPS of $0.62, and reaffirmed full-year 2026 outlook. The document presents detailed quarterly financial performance, segment results, cash flow data, and forward guidance—the hallmarks of an earnings release. Material to investors as it discloses quarterly results exceeding outlook and provides updated full-year guidance.","company_name":"QIAGEN N.V.","ticker":"QGEN","filing_date":"2026-08-07","form":"6-K","submitted_at":null,"items":[{"id":27034,"accession_number":"0001015820-26-000049","item_number":"EX-99.1","item_title":"exhibit9912026q2pressrelea.htm","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a media release announcing QIAGEN's Q2 2026 financial results, including net sales of $535 million, adjusted diluted EPS of $0.62, and reaffirmed full-year 2026 outlook. The document presents detailed quarterly financial performance, segment results, cash flow data, and forward guidance—the hallmarks of an earnings release. Material to investors as it discloses quarterly results exceeding outlook and provides updated full-year guidance.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-08-09T03:01:22.976057+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":27034,"accession_number":"0001015820-26-000049","item_number":"EX-99.1","item_title":"exhibit9912026q2pressrelea.htm","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a media release announcing QIAGEN's Q2 2026 financial results, including net sales of $535 million, adjusted diluted EPS of $0.62, and reaffirmed full-year 2026 outlook. The document presents detailed quarterly financial performance, segment results, cash flow data, and forward guidance—the hallmarks of an earnings release. Material to investors as it discloses quarterly results exceeding outlook and provides updated full-year guidance.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-08-09T03:01:22.976057+00:00","company_name":"QIAGEN N.V.","ticker":"QGEN","filing_date":"2026-08-07"}]}